SCHEMBL8683160

SCHEMBL8683160

CN(C)C(=O)OC1CCCN1C

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
DPP4 P27487 2/20 0.34
DPP8 Q6V1X1 2/20 0.34
DPP9 Q86TI2 2/20 0.34
BCHE P06276 3/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNA5 P30532 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
L3MBTL3 Q96JM7 1/20 0.32
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8681185 0.83 BCHE (0.49) SMN1; SMN2BCHECHRNB2CHRNA5CHRNA7
SCHEMBL8686148 0.81 BCHE (0.43) SMN1; SMN2DPP4DPP8DPP9BCHE
SCHEMBL21333720 0.79 DPP4 (0.40) DPP4DPP8DPP9BCHECHRM4
SCHEMBL3905171 0.79 SMN1; SMN2 (0.38) SMN1; SMN2CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL688825 0.79 SMN1; SMN2 (0.38) SMN1; SMN2CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL688697 0.79 SMN1; SMN2 (0.38) SMN1; SMN2CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL8682408 0.77 ALDH1A1 (0.38) SMN1; SMN2DPP4DPP8DPP9BCHE
Hydrochloric Acid SCHEMBL21801417 0.77 SMN1; SMN2 (0.40) SMN1; SMN2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8704065 0.77 SMN1; SMN2 (0.37) SMN1; SMN2CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL8682105 0.74 CHRM1 (0.44) SMN1; SMN2BCHECHRM1CHRM3CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed